NIAID Funding News, February 17, 2021

February 17, 2021 NIAID Funding News Read this full edition online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices Feature Articles  Writing a Winning Application—Write To Excite Create a winning application by keeping its audience—your peer reviewers—in mind as you anticipate and address their questions about your project's significance and innovation. Opportunities and Resources Focus of New NOSI—Complement Components in Immune Responses Study the roles of complement components to inform the development of adjuvants and vaccine candidates or therapeutics that target complement components. Reissued Opportunity To Join the Human Immunology Project Consortium Join a network of human immunology profiling research groups gathering data to develop molecular signatures that define immune response profiles and identify biomarkers. Notice of Special Interest for COVID-19 U01 Applications Expires in March NIAID's notice of special interest Availability of Emergency Awards for Limited Clinical Trials To Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 will expire on March 15, 2021, meaning the deadline to apply is March 14, 2021. Start Planning for HIV Structural Biology U54 Funding Opportunity Prepare now to join the Centers for HIV Structural Biology, which integrate techniques from structural biology, biochemistry, and cell biology to ultimately solve the three-dimensional structures of HIV and host cell factor complexes necessary for viral replication. In The News NIAID Peer Review and Committee Volunteers Deserve Thanks On behalf of NIAID and our research community, we gratefully acknowledge all the peer reviewers and advisory committee members who gave their valuable time and effort this past year. Virtual Review Meetings Are Virtually the Norm at NIAID Over the past 10 years, NIAID's Scientific Review Program has moved from primarily face-to-face peer review meetings to mostly teleconferencing and videoconferencing. NIAID Small Business Success Stories From 2020 Check out how 10 companies advanced their innovative technologies with NIAID small business award funds, then learn how to share your own success story. Creating Safe, Diverse Environments for NIH-Supported Conferences NIH encourages grantees to enhance diversity of conferences by increasing participation of women, underrepresented individuals from diverse racial and ethnic groups and disadvantaged backgrounds, and individuals with disabilities. Register Now for First NIAID Data Science Webinar on February 26 NIAID will conduct a series of ideas and innovation webinars to bring together experts and stakeholders in data science, infectious disease, immunology, and immune-mediated disorders. Update to Funding Opportunity for COVID-19 Personal Protective Equipment A note for those conducting or planning COVID-19-related vaccine or treatment clinical trials and clinical studies supported by NIAID's fiscal year 2020 emergency pandemic appropriations. Advice Corner Some Applications Have Deadlines for Actions Before the Due Date A variety of funding opportunity announcements either require NIAID's approval before submission or prompt you to contact a program officer for prior consultation far in advance of your application due date. Reader Questions "Do subawardees need to submit progress reports to NIAID?" "Can I spend small business funds on research in a foreign country?" New Funding Opportunities NOT-AI-21-011, Notice of Special Interest (NOSI)—Secondary Analysis of Existing Datasets for Advancing Immune-Mediated and Infectious Disease Research RFA-AI-21-006, Basic Research To Inform Vaccine and Therapeutic Development for Non-Polio Human Enteroviruses (NPEV) (R01, Clinical Trial Not Allowed) PA-21-151, NIH Support for Conferences and Scientific Meetings (Parent R13, Clinical Trial Not Allowed) RFA-AI-20-080, Human Immunology Project Consortium (HIPC) Coordinating Center (U01, Clinical Trial Not Allowed) RFA-AI-20-079, Human Immunology Project Consortium (HIPC) (U19, Clinical Trial Optional) NOT-AI-21-008, Notice of Special Interest (NOSI)—Complement in Basic Immunology (CIBI) Find other announcements at NIAID Opportunities & Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to rssproject471@gmail.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

Tweet

Postingan terkait:

— Wednesday, February 17, 2021 — Add Comment